parkinson's disease - Search News

Parkinson's disease, GLP-1

Despite Early Promise GLP-1 Disappoints in Parkinson’s Disease

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 study suggesting a potential role for GLP-1 agonists in PD.

MedPage Today · 10h

Why Did a GLP-1 Receptor Agonist Fail This Parkinson's Trial?

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients. Weekly injections of the GLP-1 receptor agonist exenatide (Byetta, Bydureon) did not slow Parkinson's disease progression or improve symptoms, the phase III Exenatide-PD3 trial showed.

The New York Times · 2d

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other conditions with newer weight-loss drugs.

Becker's Hospital Review · 1d

GLP-1 drug fails to slow Parkinson's: Study

A final-stage study has found that exenatide, a GLP-1 drug used to treat Type 2 diabetes, showed no benefit in slowing the progression of Parkinson's disease. The 96-week trial, published in The Lancet,

Daniel Barenboim, Parkinson's disease

The Associated Press on MSN · 12h

Conductor Daniel Barenboim says he's been diagnosed with Parkinson's disease

Conductor Daniel Barenboim says he has been diagnosed with Parkinson's disease. The 82-year-old issued a statement Thursday on Instagram. He has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner's Ring Cycle in Berlin.

The New York Times · 17h

Daniel Barenboim Announces He Has Parkinson’s Disease

Daniel Barenboim, the eminent conductor and pianist who stepped back from engagements in recent years citing health concerns, said Thursday that he has Parkinson’s disease.

Chicago Sun-Times · 11h

Conductor Daniel Barenboim reveals his Parkinson's disease diagnosis

The maestro has appeared more frail since 2022, canceling scheduled performances that included a new production of Wagner's Ring Cycle in Berlin.

Ozzy Osbourne, Black Sabbath and Parkinson's disease

People on MSN · 11h

Ozzy Osbourne Can No Longer Walk Due to Parkinson’s Ahead of Final Show with Black Sabbath

Ozzy Osbourne can no longer walk as his health continues to be impacted by Parkinson’s disease. On Feb. 5, Sharon Osbourne, 72, spoke to The Sun about her husband’s battle with the disease while sharing her excitement that Ozzy, 76, will be reuniting with Black Sabbath for the first time in 20 years for his final concert in July.

Newsweek on MSN · 1d

Ozzy Osbourne to Hit the Stage With Black Sabbath Amid Debilitating Parkinson's Battle

Black Sabbath will be reuniting for a performance in Ozzy Osbourne's hometown of Birmingham, U.K.. Osbourne, 76, has been battling Parkinson's disease for years, but the Prince of Darkness will not let that keep him from the stage.

Parade on MSN · 8h

Ozzy Osbourne's Heartbreaking Health Update: Inside the Rocker's Debilitating Struggle With Parkinson's Disease

What is Ozzy Osbourne's health situation? Ozzy lives with Parkinson's disease, and has had numerous surgeries over the

U.S. FDA approves Supernus' drug-device combination for Parkinson's disease

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

MedPage Today2d

FDA OKs New Wearable Treatment for Parkinson's Disease

The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...

17hon MSN

Diabetes drug similar to Ozempic showed no benefits for patients with Parkinson’s disease

A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...

10h

FDA approves wearable infusion device for advanced Parkinson disease

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

Rolling Out7d

A breakthrough in Parkinson’s disease detection

AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...

13hon MSN

Huntsville biotech firm partnering with Pfizer lands $10 million for Parkinson’s trial

A Huntsville-based biotechnology company has secured $10 million in funding to begin the trial of a new way to deliver medication to advanced Parkinson’s disease patients.

20h

Sergey Brin’s $2 Billion Quest To Tackle Parkinson’s, Bipolar Disorder And Now Autism

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Parkinson's disease, GLP-1

Daniel Barenboim, Parkinson's disease

Ozzy Osbourne, Black Sabbath and Parkinson's disease

Related topics